New Gag Rule ‘A Priority’ for Waxman

I don’t know anyone who’s completely happy with the proliferation of television ads for all manner of new drugs. I suspect we’d all be happy never to see “Bob, the Enzyte guy” again. But the general distaste over drug ads notwithstanding, Henry Waxman’s cure seems likely to be worse than the disease:

Giving FDA the power to impose two-year moratoria on consumer ads for some new drugs will be a priority for Rep. Henry Waxman as he takes the reins of the Committee on Energy and Commerce. Waxman (D-CA) told attendees at a Prescription Project conference in Washington yesterday that he would support legislation allowing the agency to ban ads for new drugs on a case-by-case basis for up to two years after approval. “It is in these first few years of a drug’s life that drug companies often aggressively market their products and engage in direct-to-consumer advertising,” Reuters quoted Waxman as saying. “This increases the number of consumer exposed to safety risks of new products long before those risks are truly understood.”

The Democrats always pitch themselves as the defender of the little guy, but here’s another example of where they believe that that selfsame little guy can’t be trusted to make decisions for himself. Apparently patients are learning about too many new drugs, and the only way to handle the problem is to allow the FDA to stifle free speech. Is it really so terrible that patients learn about drugs, and then might ask their physicians to prescribe them? It would seem to encourage more informed patients and physicians. It might even give some patients access to new treatments that could greatly reduce their suffering. Isn’t that worth some annoying television commercials?

Related Content